Providence spun out its fourth digital health startup: Praia Health, a platform designed to build stronger relationships with patients by personalizing their healthcare journeys and connecting them to relevant resources and services. The startup also announced the closing of a $20 million Series A funding round led by Frist Cressey Ventures.
As more and more organizations integrate Generative AI with Configure, Price, Quote (CPQ) systems, they declare their belief that we can aspire to incredible advancements in human health and well-being through digital transformation.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
CB Insights released a list of what it deems to be the 50 most promising digital health companies of 2023. The market research firm said that the startups on the list are working to improve four main aspects of healthcare: personalization, efficiency, equity and accessibility.
Intermountain Healthcare recently partnered with Story Health to help manage patients’ heart failure by increasing access to specialty care. Under the partnership, Intermountain clinicians are working with Story’s health coaches to help patients keep up with their treatment plans while they’re outside the walls of the doctor’s office.
Avenda Health, a startup focused on personalized prostate cancer care, recently received 510(k) clearance from the FDA for its cancer mapping platform. The platform uses a patient’s own diagnostic data to define the extent of the disease and create a cancer probability map with optimal treatment margins.
The latest generation of health and wellness offerings enables employers to provide tailored solutions to their workforce. These apps and programs often leverage big data analytics and the human touch to both identify and connect with employees.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The collaboration will build on AdventHealth's existing genomics and personalized health program, leveraging data to predict disease progression and response to treatments. Sema4's Centrellis data platform will be a core part of the new program.